Status:

RECRUITING

A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

Lead Sponsor:

Indivi AG

Conditions:

Mild Cognitive Impairment (MCI)

Mild Alzheimer Disease

Eligibility:

All Genders

50-90 years

Brief Summary

The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's di...

Eligibility Criteria

Inclusion

  • Participant is part of BU-ADRC cohort.
  • Participant is diagnosed with MCI, mild AD, or is classified as HC per BU-ADRC, with available required data for inclusion obtained less than 2 years before the inclusion.
  • Participant is between 50 and 90 years old, included.
  • Participant is able to use a smartphone.
  • Participant has sufficient knowledge of the English language.
  • Participant is able to and has an intention to follow the study procedures.
  • Informed Consent as documented by signature.

Exclusion

  • Participant has any neurological condition that may be contributing to cognitive impairment (above and beyond that caused by the subject's MCI or AD).
  • Participant has psychiatric diagnosis or symptoms, (e.g., hallucinations, major depression, or delusions) that could interfere with study procedures.
  • Participant has a history of stroke or seizures within the last 24 months.
  • Participant has a Geriatric Depression Scale (GDS) score ≥8.
  • Participant has a severe visual or hearing impairment that would interfere with capacity to perform cognitive assessments.
  • Known or suspected non-compliance.

Key Trial Info

Start Date :

September 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT07174869

Start Date

September 1 2025

End Date

June 1 2026

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Boston University School of Medicine

Boston, Massachusetts, United States, 02118